Pancreatic Cancer Research

ResearcherGenentechNo recent work listed

Nicole M. Sodir

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9919-2190; OpenAlex author ID A5034898378. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer. Co-author DOI 10.1038/s41467-023-40798-6↗
  2. MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype. Co-author DOI 10.1158/2159-8290.cd-19-0435↗
  3. Ibrutinib exerts potent antifibrotic and antitumor activities in mouse models of pancreatic adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-14-2852↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gérard I. Evan · 3 shared papers, 2015–2023 · strength 0.26
  2. Laura Soucek · 2 shared papers, 2015–2020 · strength 0.15
  3. David J. Propper · 1 shared paper, 2023 · strength 0.12
  4. Corina E. Antal · 1 shared paper, 2023 · strength 0.12
  5. Jan C. Lumibao · 1 shared paper, 2023 · strength 0.12
  6. Haiyong Han · 1 shared paper, 2023 · strength 0.12
  7. Andrew M. Lowy · 1 shared paper, 2023 · strength 0.12
  8. Dannielle D. Engle · 1 shared paper, 2023 · strength 0.12
  9. Erkut Hasan Borazanci · 1 shared paper, 2023 · strength 0.12
  10. Ronald M. Evans · 1 shared paper, 2023 · strength 0.12
  11. Hervé Tiriac · 1 shared paper, 2023 · strength 0.12
  12. Daniel D. Von Hoff · 1 shared paper, 2023 · strength 0.12
  13. Michael T. Barrett · 1 shared paper, 2023 · strength 0.12
  14. Kim Pedersen · 1 shared paper, 2015 · strength 0.05
  15. Toni Jauset · 1 shared paper, 2015 · strength 0.05
  16. Daniel Massó-Vallés · 1 shared paper, 2015 · strength 0.05
  17. Joaquı́n Arribas · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.